ACF has been shown to be a potent HIF-1α inhibitor, disrupting the dimerization of HIF-1α (or HIF-2α) with HIF-1β thereby inhibiting HIF-1 transcriptional activity in various cancer cell lines20,24 (Fig. 2). Here, EPAS1 is linked to cancer.